Chipscreen ^Public

Chipscreen is an integrated biotech company that specializes in the discovery and development of novel small molecule pharmaceuticals. The company has a strong focus on the development of drugs for serious diseases such as malignant tumors, metabolic diseases, autoimmune diseases, central nervous system disorders, and antiviral treatments. They have successfully utilized their proprietary chemical genomics-based discovery platform to develop a portfolio of clinical and preclinical stage programs in various therapeutic areas. Chipscreen's business strategy involves generating differentiated drug candidates and either developing them in-house or partnering with other organizations for research, preclinical, and clinical stages. Established in 2001 by Chinese returnees from the United States, Chipscreen aims to be a leading drug discovery and pharmaceutical company in China.